Amydis bags $2.5 million NIH grant to develop first eye test for key ALS biomarker

Ovation.io and PrecisionLife team to develop drug-response biomarkers for GLP-1 therapies

GLP-1 therapies are among the fastest-growing drug classes worldwide, projected to drive a $95 billion obesity market by 2030

Surfix Diagnostics, NKI and CRCbioscreen join forces to validate biomarkers for colorectal cancer screening

Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality

BioFluidica to introduce next-generation biomarker isolation platform

BioFluidica LiquidScan harnesses the power of microfluidics

Roche moves to acquire PathAI for up to $1.05 billion in major AI pathology push

The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities

Project Serotonin launches AI-powered gut health protocol

The precision health platform integrates genetics, biomarkers, diet, and lifestyle data to deliver personalised gut health interventions and therapy support

FDA grants breakthrough status to Laguna's mRNA blood test for schizophrenia diagnosis

The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay

Betting on NK-cell innovation and combination immunotherapy to build global clinical-stage biotech: Dr Maloy Ghosh, CSO, Zumutor Biologics

Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies

Leinco Technologies and CellCarta partner to advance proteomics in immuno-oncology

The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use

Laguna Diagnostics secures FDA breakthrough tag for mRNA test in psychiatric diagnosis

The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder